Protocol Details
Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis
This study is currently recruiting participants.
Summary | Eligibility | Citations | Contacts
Summary
Number |
03-I-0041 |
Sponsoring Institute |
National Institute of Allergy and Infectious Diseases (NIAID) |
Recruitment Detail |
Type: Participants currently recruited/enrolled |
Referral Letter Required |
Yes |
Population Exclusion(s) |
None |
Special Instructions |
Currently Not Provided |
Keywords |
Children; |
Recruitment Keyword(s) |
Mastocytosis; |
Condition(s) |
Mastocytosis |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
|
Patients up to 21 years of age with childhood-onset mastocytosis may be eligible for this study. Candidates must have one or more of the following abnormalities, which indicate severe disease: enlarged liver or spleen; diffuse skin involvement; history of gastrointestinal bleeding or peptic ulcer; bone marrow biopsy with abnormal mast cells either in number or shape; elevated blood levels of the enzyme tryptase; or abnormal hemoglobin, white blood cells, platelets, or clotting factors.
Participants will have a medical history and physical examination; various blood tests, including studies to identify genetic changes that are important in the growth, development, and functioning of human mast cells; and bone marrow aspiration and biopsy. For the bone marrow procedure, the skin over the hipbone and the outer surface of the bone itself are numbed with an injection of local anesthesia. Then, a special needle is inserted into the hipbone and about 2 tablespoons of bone marrow are drawn into a syringe. Another needle is then inserted through the first needle to collect a small piece of the bone marrow. Pain will be managed according to the individual patient's needs. Additional procedures, such as a gastroenterology consultation, colonoscopy to examine the colon, or computerized axial tomography (CT) or ultrasound of the abdomen to assess the liver and spleen, may be done if medically indicated. Standard medical treatment, including antihistamines for itching or steroids for abdominal cramping or diarrhea, will be recommended as appropriate.
Patients' biologic parents may also be enrolled to provide a blood sample for genetic analysis and a bone marrow aspirate and biopsy for clinical and research purposes.
Patients will return to NIH once a year for follow-up evaluations until their disease is stable or until the 5-year study ends.
Eligibility
INCLUSION CRITERIA:
Children with tissue-diagnosed pediatric-onset mastocytosis formerly enrolled in protocols 90-I-0120, and 93-I-0136 or per physician referral with more severe disease as indicated by one of the following parameters:
-Hepatomegaly or splenomegaly;
-Diffuse cutaneous mastocytosis;
-History of gastrointestinal bleeding or peptic ulcer disease;
-Bone marrow biopsy with abnormal numbers or shaped mast cells or abnormal flow cytometry;
-Serum tryptase greater than 20ng/ml;
-Hematologic abnormalities such as an increase WBC, thrombocytosis, and/or an increase in PT and/or PTT.
INCLUSION CRITERIA-SUBJECT:
-Age birth to 21.0 years of age at the time of entry into the protocol
-Diagnosis of mastocytosis by skin examination or histologic evidence in a skin or bone marrow biopsy
-Subject has a primary medical care provider outside the NIH
-Subject or parent or guardian is able to give informed consent
INCLUSION CRITERIA-PARENT:
-A child with the diagnosis of mastocytosis by skin examination or histologic evidence in a skin or bone marrow biopsy
-Subject has a primary medical care provider outside the NIH
EXCLUSION CRITERIA - SUBJECT:
-Age greater than or equal to 21.0 years
-No primary care physician
-Has AIDS or is HIV Positive
Citations:
Contacts:
Principal Investigator |
Referral Contact |
For more information http://clinicalstudies.info.nih.gov. |
| Melody C. Carter, M.D. National Human Genome Research Institute (NHGRI) 333 Cassell Drive Suite 1200 Baltimore, MD 21224 (443) 740-2921 jebw@nhgri.nih.gov |
Linda M. Scott, C.R.N.P. National Human Genome Research Institute (NHGRI) 333 Cassell Drive Suite 1200 Baltimore, MD 21224 (443) 740-2921 jebw@nhgri.nih.gov |
Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 prpl@mail.cc.nih.gov |
Clinical Trials Number:
NCT00050193
QUESTIONS?
Contact the Patient Recruitment and Public Liaison Office for:
- Details on how to participate in a study
- Details on how to refer a patient to a study
NIH Clinical Studies Information Request
Contact the Office of Communications for:
- General information about the NIH Clinical Center
Contact the Department Clinical Research Informatics, (DCRI) for:
- Technical questions about Adobe Acrobat and the PDF format
- Technical questions about this web server




